We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Kforce
KFRC
$1.05B
| $631K | 0.06% |
17,963
-2,172
| -11% | -$75.3K |
|
552
Dana Inc
DAN
$2.94B
| $628K | 0.06% |
+35,388
| New | +$628K |
|
553
Sonoco
SON
$5.64B
| $627K | 0.06% |
10,192
+5,949
| +140% | +$342K |
|
554
Aflac
AFL
$64.5B
| $626K | 0.06% |
+12,516
| New | +$603K |
|
555
Insmed
INSM
$28.7B
| $625K | 0.06% |
+21,513
| New | +$558K |
|
556
Open Text
OTEX
$6.23B
| $625K | 0.06% |
+16,268
| New | +$595K |
|
557
Ingredion
INGR
$6.49B
| $623K | 0.06% |
6,576
+125
| +2% | +$11.8K |
|
558
NMI Holdings
NMIH
$3.31B
| $620K | 0.06% |
+23,958
| New | +$546K |
|
|
SGMO
559
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $620K | 0.06% |
65,031
-13,569
| -17% | -$139K |
|
560
Bank of America
BAC
$441B
| $619K | 0.06% |
22,426
+12,632
| +129% | +$357K |
|
|
ACH
561
Accendra Health
ACH
$224M
| $618K | 0.06% |
150,677
+19,877
| +15% | +$126K |
|
|
SPR
562
DELISTED
Spirit AeroSystems
SPR
| $618K | 0.06% |
6,756
+3,605
| +114% | +$318K |
|
|
AYX
563
DELISTED
Alteryx Inc
AYX
| $616K | 0.06% |
7,341
-15,556
| -68% | -$1.12M |
|
564
Regions Financial
RF
$26.8B
| $615K | 0.06% |
43,479
+14,167
| +48% | +$217K |
|
565
Independent Bank Corp
IBCP
$793M
| $614K | 0.06% |
+28,565
| New | +$642K |
|
566
American Vanguard Corp
AVD
$73.5M
| $613K | 0.06% |
35,604
-9,034
| -20% | -$159K |
|
567
MSCI
MSCI
$41.2B
| $613K | 0.06% |
+3,081
| New | +$536K |
|
|
BEST
568
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $613K | 0.06% |
5,864
+4,589
| +360% | +$479K |
|
|
BVH
569
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $613K | 0.06% |
20,726
-7,120
| -26% | -$218K |
|
570
Boston Scientific
BSX
$71.4B
| $612K | 0.06% |
15,955
-686
| -4% | -$26.2K |
|
|
ARGO
571
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $612K | 0.06% |
+8,657
| New | +$589K |
|
572
MPLX
MPLX
$61.3B
| $610K | 0.06% |
18,551
-2,688
| -13% | -$90.3K |
|
573
Analog Devices
ADI
$184B
| $609K | 0.06% |
+5,784
| New | +$580K |
|
574
Mammoth Energy Services
TUSK
$142M
| $609K | 0.06% |
36,600
-5,500
| -13% | -$117K |
|
575
Neurocrine Biosciences
NBIX
$16.2B
| $608K | 0.06% |
6,900
-3,500
| -34% | -$293K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.